Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2024-07-11 | 2025-06-13 | 232735 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2024-10-11 | 2025-01-09 | 240075 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 1MG 100000UNIT | CREAM | Actual shortage | 2025-10-30 | 2025-10-30 | 270657 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 1MG 100000UNIT | CREAM | Actual shortage | 2025-11-20 | 2025-12-11 | 272286 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2020-01-09 | 2020-02-13 | 102884 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-01 | 110791 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110794 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-06-25 | 2021-02-18 | 118957 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2023-08-17 | 2023-10-12 | 202200 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1582 |
| TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
| TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1609 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105570 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-06-17 | 2021-10-21 | 141119 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2023-10-05 | 2024-03-18 | 206383 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Actual shortage | 2024-08-08 | 2024-08-08 | 234876 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97605 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |